Dr Paul England

Solicitor, Taylor Wessing LLP

Dr Paul Alexander England is the senior knowledge lawyer in the UK Patents Group, specialising in advisory work for clients and the Patents Group on contentious patent matters.

Paul is also Secretary of the Academy of Experts, a professional body for expert witnesses, founded in 1987, which establishes and promotes high objective standards.

Paul has a particular interest in the life sciences sector, having begun his career as a scientist and taken a doctorate in biochemistry and molecular biology at the University of Oxford.

Paul publishes and speaks on patent law widely, including for Pfizer, Abbott, Takeda, Roche, Viatris, and is an author of the critically acclaimed A Practitioner's Guide to European Patent Law and A User's Guide to Intellectual Property in the Life Sciences.

Paul is a reviewer for the Journal of Intellectual Property Law and Practice (Oxford University Press) and a correspondent for BioScience Law Review.

Contributed to

1

Intellectual property protection for personalised medicines

Practice Notes

This Practice Note discusses the various intellectual property (IP) rights that can be used in relation to personalised medicines. It explains what personalised medicines are and how they are identified. It explores second and subsequent medical use claims, sub-population claims, as well as monoclonal antibody patents. It examines the plausibility threshold for inventive step and sufficiency, and plausibility and enablement of functional claims. It also discusses patentability of diagnostic products and methods and supplementary protection certificates (SPCs) for targeted treatments. This Practice Note also covers other IP considerations, such as regulatory data protection and market exclusivity, the protection of trade secret as well as copyright and database rights.

Life Sciences